- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01986517
Feedback and Psychotherapeutic Competencies
March 19, 2015 updated by: Florian Weck, Goethe University
Impact of Feedback on the Devolpment of Psychotherapeutic Competencies: a Randomized Controlled Trial
The purpose of the current study is to examine the influence of feedback on psychotherapeutic competency.
The present randomized controlled study compares a feedback condition with a non-feedback condition.
Therapists in the feedback condition receive feedback after every fourth session.
The feedback is given by two trained and independent raters.
The raters are licenced and experienced psychotherapists.
Therapists in the non-feedback condition receive no feedback during the psychotherapy.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
20
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Hessen
-
Frankfurt/ Main, Hessen, Germany, 60486
- Department of Clinical Psychology and Psychotherapy of Goethe University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 65 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Therapists
Inclusion Criteria:
- Having successfully completed the interim audit
- Having started to treat ambulant patients
- Remaining at least 6 month in the ambulance
Exclusion Criteria:
-
Patients
Inclusion Criteria:
- Meeting ICD 10 criteria for a mental disorder
- Informed consent
Exclusion Criteria:
- Currently in psychotherapy
- Suicidal tendency
- Clinical diagnosis of alcohol or drug addiction, acute schizophrenia, schizoaffective disorder or bipolar disorder
- Clinical diagnosis of personality disorder cluster A (odd disorders) and B (dramatic, emotional or erratic)
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Feedback
Therapists assigned to this group will receive standardized feedback on their psychotherapeutic competency after every fourth treatment session with a patient for a period of 20 therapy sessions.
The feedback will be given by two experienced raters who are licensed as psychological psychotherapists.
|
|
|
Experimental: No feedback
Therapists assigned to this group will receive no feedback
|
Therapists will receive no feedback.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Cognitive Therapy Scale (CTS)
Time Frame: participants will be followed for the duration of psychotherapy, an expected average of 20 weeks
|
external-assessment measure that assesses psychotherapeutic competency during a cognitive therapy session.
CTS will be used by two trained raters licensed as psychological psychotherapists.
|
participants will be followed for the duration of psychotherapy, an expected average of 20 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Helping Alliance Questionaire (HAQ)
Time Frame: participants will be followed for the duration of psychotherapy, an expected average of 20 weeks
|
self-report measure to assess therapeutic alliance from the therapists perspective (therapist version; HAQ-T) and the patients perspective (HAQ-P)
|
participants will be followed for the duration of psychotherapy, an expected average of 20 weeks
|
|
Berner Stundenbögen Version 2000
Time Frame: participants will be followed for the duration of psychotherapy, an expected average of 20 weeks
|
self-report measure to assess therapeutic relationship from the therapists perspective (therapist version, TSTB) and the patients perspective (patient version; PSTB)
|
participants will be followed for the duration of psychotherapy, an expected average of 20 weeks
|
|
Global Assessment of Functioning (GAF)
Time Frame: participants will be followed for the duration of psychotherapy, an expected average of 20 weeks
|
external measure to assess the global functioning of the patient
|
participants will be followed for the duration of psychotherapy, an expected average of 20 weeks
|
|
Supervisory Questionaire (SQ)
Time Frame: participants will be followed for the duration of psychotherapy, an expected average of 20 weeks
|
self-report measure to assess the therapists self-opening
|
participants will be followed for the duration of psychotherapy, an expected average of 20 weeks
|
|
Supervisee Levels Questionaire (SLQ-R)
Time Frame: participants will be followed for the duration of psychotherapy, an expected average of 20 weeks
|
self-report measure to assess the therapists self-awareness
|
participants will be followed for the duration of psychotherapy, an expected average of 20 weeks
|
|
Counseling Self-Estimate Inventory (COSE)
Time Frame: participants will be followed for the duration of psychotherapy, an expected average of 20 weeks
|
self-report measure to assess self efficacy of the therapist
|
participants will be followed for the duration of psychotherapy, an expected average of 20 weeks
|
|
Fear of negative evaluation scale (Skala Angst vor negativer Bewertung; SANB)
Time Frame: participants will be followed for the duration of psychotherapy, an expected average of 20 weeks
|
self-report measure to assess fear of evaluation
|
participants will be followed for the duration of psychotherapy, an expected average of 20 weeks
|
|
Brief Symptom Inventory (BSI)
Time Frame: participants will be followed for the duration of psychotherapy, an expected average of 20 weeks
|
self-report measure to assess aspects of general psychopathology
|
participants will be followed for the duration of psychotherapy, an expected average of 20 weeks
|
|
Beck Depression Inventory II (BDI II)
Time Frame: participants will be followed for the duration of psychotherapy, an expected average of 20 weeks
|
self-report measure to assess depressive symptoms
|
participants will be followed for the duration of psychotherapy, an expected average of 20 weeks
|
|
Beck Anxiety Inventory (BAI)
Time Frame: participants will be followed for the duration of psychotherapy, an expected average of 20 weeks
|
self-report measure to assess anxiety symptoms
|
participants will be followed for the duration of psychotherapy, an expected average of 20 weeks
|
|
Client Satisfaction Questionaire (CSQ8)
Time Frame: participants will be followed for the duration of psychotherapy, an expected average of 20 weeks
|
self-report measure to assess satisfaction with therapy
|
participants will be followed for the duration of psychotherapy, an expected average of 20 weeks
|
|
Health-related quality of life (SF-12)
Time Frame: participants will be followed for the duration of psychotherapy, an expected average of 20 weeks
|
self-report measure to assess health-related quality of life
|
participants will be followed for the duration of psychotherapy, an expected average of 20 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
November 1, 2013
Primary Completion (Actual)
March 1, 2015
Study Completion (Actual)
March 1, 2015
Study Registration Dates
First Submitted
November 11, 2013
First Submitted That Met QC Criteria
November 11, 2013
First Posted (Estimate)
November 18, 2013
Study Record Updates
Last Update Posted (Estimate)
March 20, 2015
Last Update Submitted That Met QC Criteria
March 19, 2015
Last Verified
March 1, 2015
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- Feedback-01
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Mental Disorders
-
Kansas State UniversityAugusta University; Dartmouth College; University of CincinnatiEnrolling by invitationMental Disorders, Severe | Mental Illness PersistentUnited States
-
Rutgers, The State University of New JerseyRecruiting
-
Virginia Commonwealth UniversityCompletedMental Health DisordersUnited States
-
Johns Hopkins UniversityEunice Kennedy Shriver National Institute of Child Health and Human Development...CompletedMental Health DisordersCongo
-
Norwegian University of Science and TechnologySt. Olavs HospitalCompletedMental Health DisordersNorway
-
York UniversityCanadian Institutes of Health Research (CIHR); North York General HospitalCompletedMental Health DisordersCanada
-
VA Boston Healthcare SystemUS Department of Veterans AffairsCompletedMental Health DisordersUnited States
-
University of ManchesterEuropean Research CouncilRecruitingMental Disorders, SevereUnited Kingdom
-
Fundació Institut de Recerca de l'Hospital de la...CompletedMental Disorders, SevereSpain
-
University of North Carolina, Chapel HillU.S. Department of JusticeCompletedMental Disorders, SevereUnited States
Clinical Trials on Feedback after every fourth session
-
Suleyman Demirel UniversityRecruitingSocial Skills | Leadership | Mentoring | Peer Group | Nurse | Program Evaluation | Empathy SkillsTurkey (Türkiye)
-
Riphah International UniversityCompletedCoronary Artery Bypass GraftPakistan
-
Clinique Romande de ReadaptationCompletedStroke | Multiple Sclerosis | Cerebral Palsy | Parkinson Disease | Spinal Cord Injuries | People With Impaired Lower Extremity FunctionSwitzerland
-
University of PittsburghNational Heart, Lung, and Blood Institute (NHLBI); National Institutes of Health...CompletedOverweight and ObesityUnited States
-
Centre Paul StraussCentre de recherche du Centre hospitalier universitaire de SherbrookeActive, not recruitingTriple-negative Breast CancerFrance
-
Hospices Civils de LyonCompleted
-
Nantes University HospitalTerminated
-
Hamilton Health Sciences CorporationNational Research System-College of Family Physicians of CanadaUnknownChronic Kidney DiseaseCanada
-
University of ManitobaCompleted
-
University of ChicagoCompleted